Preeclampsia
 

Preeclampsia

   

Pre-Eclampsia and Eclampsia - BP Measurement

Home
Pregnancy Calendar
Pregnancy
Pregnancy and Childbirth
Pregnancy and Childbirth
Pregnancy and Childbirth
Pregnancy and Childbirth
Pregnancy and Childbirth
Pregnancy Date Calculator
Symptoms & Signs
Pregnancy - Antenatal Care
Pregnancy
Gestational Age
Gestational Age Intro
Morning Sickness
Smoking
Obesity
Diabetes in Pregnancy
Gestational Diabetes
Liver
Infections
Teen Pregnancy
Depression in Pregnancy
Headache
PET Definitions
Aetiology - Pre-Eclampsia and Eclampsia
Antepartum Haemorrhage
Intrautrine Growth Restriction - IUGR
Breech Presentation
Twins
Teenage Pregnancy.
Thromboprophylaxis in pregnancy and the puerperium
Premature Labour
Post-Maturity
Induction Of Labour
Planned Delivery
Water Birth
Operative Vaginal Delivery-Forceps Delivery
Vacuum Extraction Delivery
Shoulder Dystocia
Caesarean Section
Pregnancy and Childbirth
Obstetric Emergencies
Puerperium
Post-Partum Haemorrhage
Uterine Rupture
Childbirth
Perinatal Mortality
Breast Feeding
 

PRE-ECLAMPSIA

AND ECLAMPSIA

 

Blood pressure measurement.

 

 

 

Lancet. 1998 Sep 5;352(9130):777-81.

 

Randomised trial of management of hypertensive pregnancies by Korotkoff phase IV or phase V.

Brown MA,

Buddle ML,

Farrell T,

Davis G,

Jones M.

Department of Renal Medicine, St George Hospital, University of New South Wales, Kogarah, Australia. mark.brown@bigpond.com

Background:

There is debate about whether diastolic blood pressure should be recorded as the fourth (muffling, K4) or fifth (disappearance, K5) Korotkoff sound in pregnancy. We compared maternal and fetal outcomes and the likelihood that episodes of severe hypertension would be recorded when hypertensive pregnancies were managed according to either K4 or K5.

Methods:

220 pregnant women with diastolic hypertension (K4 > or =90 mm Hg) after the 20th week of gestation were enrolled in a prospective randomised study at two obstetric units in Australia; they were randomly assigned management with K4 (n=103) or K5 (n=117) for the remainder of the pregnancy. Clinical management was according to a uniform department protocol. Analysis was by intention to treat. All the women completed the trial.

Findings:

An episode of severe hypertension (systolic > or =170 mm Hg, diastolic > or =110 mm Hg, or both) was more likely to be recorded with use of K4 than with use of K5 (39 [38%] vs 30 [26%] women, p=0.051), mainly because of a greater likelihood that severe diastolic hypertension would be recorded (34 [33%] vs 20 [17%], p=0.006). The frequency of severe systolic hypertension and simultaneous severe systolic and diastolic hypertension did not differ between groups. Pregnancy was prolonged by an average of 2 weeks in both groups, and there were no significant differences between the groups in laboratory data, requirements for antihypertensive treatment, birthweight, fetal growth retardation, or perinatal mortality. There was no eclampsia or significant maternal morbidity in either group.

Interpretation:

A change from use of K4 to K5 would mean that one fewer case of severe diastolic hypertension would be recorded for every six hypertensive pregnancies, but all other episodes of severe hypertension would be recorded with similar frequency. Since the K4/K5 difference is smaller in hypertensive than in normotensive pregnant women and since K5 is closer to the actual intra-arterial pressure and more reliably detected, universal adoption of K5 to record diastolic blood pressure in hypertensive pregnancy should be considered.

Back Home Up Next

 

pregnancy

PRE-ECLAMPSIA AND ECLAMPSIA

Aetiology
Definitions
Initial assessment
BP Measurement
Proteinuria
Maternal Monitoring
Fetal Assessment
Medication
Prevention
Seizures - Eclampsia
Fluid Balance
Planning Delivery
Post Delivery
Post Discharge
Maternal Mortality